Compare SRI & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRI | MIST |
|---|---|---|
| Founded | 1965 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.7M | 176.3M |
| IPO Year | 1997 | 2019 |
| Metric | SRI | MIST |
|---|---|---|
| Price | $7.39 | $1.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $16.00 | $8.00 |
| AVG Volume (30 Days) | 306.3K | ★ 1.2M |
| Earning Date | 05-01-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $824,444,000.00 | N/A |
| Revenue This Year | N/A | $2,915.14 |
| Revenue Next Year | $4.73 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 18.46 | N/A |
| 52 Week Low | $4.60 | $1.00 |
| 52 Week High | $9.71 | $3.06 |
| Indicator | SRI | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 51.90 | 36.21 |
| Support Level | $7.26 | $1.00 |
| Resistance Level | $7.48 | $1.42 |
| Average True Range (ATR) | 0.30 | 0.06 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 67.95 | 5.71 |
Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).